Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo

This publication has 25 references indexed in Scilit:

• Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
  British Journal of Cancer, 2011
• Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
  BMC Cancer, 2011
• Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non‐Small‐Cell Lung Cancer
  BioMed Research International, 2011
• Targeting Notch to Target Cancer Stem Cells
  Clinical Cancer Research, 2010
• Alterations of the Notch pathway in lung cancer
  Proceedings of the National Academy of Sciences, 2009
• Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials
  Clinical Cancer Research, 2009
• Emerging role of Notch in stem cells and cancer
  Cancer Letters, 2009
• Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
  Cancer Research, 2009
• Slug is a direct Notch target required for initiation of cardiac cushion cellularization
  Journal of Cell Biology, 2008
• Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
  Journal of Cell Biology, 2007